Genetic variation in GREM1 is a risk factor for fibrosis in pulmonary sarcoidosis

Tissue Antigens

Volumn 77, Issue 2, 2011, Pages 112-117

  Heron, M ^a   Van Moorsel, C H M ^a   Grutters, J C ^a   Huizinga, T W J ^b   Van Der Helm Van Mil, A H M ^b   Nagtegaal, M M ^a   Ruven, H J T ^a   Van Den Bosch, J M M ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fibrosis; GREM1; Pulmonary sarcoidosis; Single nucleotide polymorphism

Indexed keywords

GREMLIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GREM1 GENE; HOMOZYGOSITY; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; THORAX RADIOGRAPHY;

ALLELES; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY FIBROSIS; RISK FACTORS; SARCOIDOSIS, PULMONARY;

EID: 78650954975     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01590.x     Document Type: Article

References (40)

1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007: 357: 2153-65.
2. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984: 310: 235-44.
3. Sato H, Williams HR, Spagnolo P et al. CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis. Eur Respir J 2009: 35: 324-30.
4. Kruit A, Grutters JC, Ruven HJ et al.Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest 2006: 129: 1584-91.
5. Prasse A, Pechkovsky DV, Toews GB et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 2006: 173: 781-92.
6. Wahlstrom J, Katchar K, Wigzell H, Olerup O, Eklund A, Grunewald J. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med 2001: 163: 115-21.
7. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1998: 1: 673-83.
8. Gazzerro E, Pereira RC, Jorgetti V, Olson S, Economides AN, Canalis E. Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Endocrinology 2005: 146: 655-65.
9. Bellusci S, Henderson R, Winnier G, Oikawa T, Hogan BL. Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development 1996: 122: 1693-702.
10. Lu MM, Yang H, Zhang L, Shu W, Blair DG, Morrisey EE. The bone morphogenic protein antagonist gremlin regulates proximal-distal patterning of the lung. Dev Dyn 2001: 222: 667-80.
11. Shi W, Zhao J, Anderson KD, Warburton D. Gremlin negatively modulates BMP-4 induction of embryonic mouse lung branching morphogenesis. Am J Physiol Lung Cell Mol Physiol 2001: 280: L1030-9.
12. Topol LZ, Bardot B, Zhang Q et al. Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin. J Biol Chem 2000: 275: 8785-93.
13. Michos O, Panman L, Vintersten K, Beier K, Zeller R, Zuniga A. Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 2004: 131: 3401-10.
14. Roxburgh SA, Murphy M, Pollock CA, Brazil DP. Recapitulation of embryological programmes in renal fibrosis-the importance of epithelial cell plasticity and developmental genes. Nephron Physiol 2006: 103: 139-48.
15. Warburton D, Tefft D, Mailleux A et al. Do lung remodeling, repair, and regeneration recapitulate respiratory ontogeny? Am J Respir Crit Care Med 2001: 164: S59-62.
16. Koli K, Myllarniemi M, Vuorinen K et al. Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. Am J Pathol 2006: 169: 61-71.
17. Myllarniemi M, Lindholm P, Ryynanen MJ et al. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Am J Respir Crit Care Med 2008: 177: 321-9.
18. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999: 14: 735-7.
19. American Thoracic Society/European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002: 165: 277-304.
20. Hunninghake GW, Costabel U, Ando M et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999: 16: 149-73.
21. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005: 37: 1217-23.
22. Griffiths-Jones S, Saini HK, van DS, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008: 36: D154-8.
23. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004: 74: 765-9.
24. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005: 21: 263-5.
25. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003: 73: 1162-9.
26. Ardlie KG, Kruglyak L, Seielstad M. Patterns of linkage disequilibrium in the human genome. Nat Rev Genet 2002: 3: 299-309.
27. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993: 75: 843-54.
28. Reinhart BJ, Slack FJ, Basson M et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000: 403: 901-6.
29. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 2008: 105: 1608-13.
30. Costello CM, Cahill E, Martin F, Gaine S, McLoughlin P. Role of gremlin in the lung: development and disease. Am J Respir Cell Mol Biol 2010: 42: 517-23.
31. Dolan V, Murphy M, Sadlier D et al. Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. Am J Kidney Dis 2005: 45: 1034-9.
32. Boers W, Aarrass S, Linthorst C, Pinzani M, Elferink RO, Bosma P. Transcriptional profiling reveals novel markers of liver fibrogenesis: gremlin and insulin-like growth factor-binding proteins. J Biol Chem 2006: 281: 16289-95.
33. McKnight AJ, Patterson CC, Pettigrew KA et al. A GREM1 gene variant associates with diabetic nephropathy. J Am Soc Nephrol 2010: 21: 773-81.
34. Fonseca C, Lindahl GE, Ponticos M et al. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med 2007: 357: 1210-20.
35. Costello CM, Howell K, Cahill E et al. Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2008: 295: L272-84.
36. Arcasoy SM, Christie JD, Pochettino A et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001: 120: 873-80.
37. Sulica R, Teirstein AS, Kakarla S, Nemani N, Behnegar A, Padilla ML. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest 2005: 128: 1483-9.
38. Nunes H, Humbert M, Capron F et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006: 61: 68-74.
39. Newman JH, Wheeler L, Lane KB et al. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med 2001: 345: 319-24.
40. Takahashi H, Goto N, Kojima Y, Tsuda Y, Morio Y, Muramatsu M, Fukuchi Y. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2006: 290: L450-8.